About Inogent Laboratories Private Limited
Data last updated:
Inogent Laboratories Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Aragen Life Sciences Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 June 2005.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC046402. Its GSTIN is 36AABCI3898N1ZV (Telangana). The company held 3 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹45 Cr and a paid-up capital of ₹16.13 Cr. It was led by directors including Venkata Krishna Reddy Gunupati and Venkata Sanjayreddy Gunupati.
Its last annual general meeting (AGM) was held on 17 July 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2017, the company reported a revenue of ₹206.9 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹23.95 Cr (net margin 11.6%) and EBITDA of ₹49.18 Cr (EBITDA margin 23.8%).
The company had about 586 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹105 Cr on record. Court records list 11 cases involving the company, including 9 filed by the company and 2 filed against it. The company has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹39 Cr; the latest was in September 2016. Its 8 peer companies in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Vardhman Chemtech Limited with revenue of ₹208.69 Cr.
The last known website on record is inogent.com.
Company details
CIN history
Inogent Laboratories has one previous CIN (Corporate Identification Number): U24239AP2005PTC046402. The current CIN is U24239TG2005PTC046402, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC046402 | Current |
| U24239AP2005PTC046402 | Previous |
Contact details
Inogent Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is inogent.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressPlot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, API Manufacturers
To see the full contact details of Inogent Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Inogent Laboratories are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Inogent Laboratories Private Limited, buy the company report.
Financials of Inogent Laboratories Private Limited
FY 2017 filings availableInogent Laboratories Private Limited reported revenue of ₹206.9 Cr (up 18% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year. EBITDA rose 55% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹49.18 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹23.95 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 23.8% | ||
| Net Profit Margin | 11.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Inogent Laboratories Private Limited, buy the company report.
Board of directors of Inogent Laboratories Private Limited
Inogent Laboratories has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Krishna Reddy Gunupati Also directs: Ubiquitous Construction LLP, Marwell Management & Consultants LLP, Vertex Projects LLP and 5 more | Director | 01 Jun 2005 | 21 Years 4 Months | As last reported |
| Venkata Sanjayreddy Gunupati Also directs: Vertex Projects LLP, GVK Natural Resources Private Limited, Novopan Industries Private Limited and 5 more | Director | 01 Jun 2005 | 21 Years 4 Months | As last reported |
| Davinder Singh Brar Also directs: Excelra Knowledge Solutions Private Limited, Epl Limited, Mountain Trail Foods Private Limited and 5 more | Director | 30 Sep 2005 | 21 Years 0 Months | As last reported |
| Manmahesh Kantipudi Also directs: Aragen Life Sciences Limited, Aragen Biologics Private Limited, Zeroharm Sciences Private Limited and 3 more | Director | 14 Mar 2016 | 10 Years 7 Months | As last reported |
Peer comparison
Inogent Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vardhman Chemtech Limited | ₹208.69 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| Aktinos Pharma Private Limited | ₹207.85 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India | |||
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | 30.0% | Aran Road, Ameerpet, Hyd-016, Telangana, India | |||
| Inogent Laboratories Private Limitedthis company | ₹206.9 Cr (FY 2017) | ₹23.95 Cr | 11.6% | 18.0% | Hyderabad, Telangana, India | |
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Alaina Healthcare Private Limited | ₹205.55 Cr (FY 2025) | 21.0% | Baddi, Himachal Pradesh, India | |||
| Swati Spentose Private Limited | ₹205.55 Cr (FY 2024) | 11.0% | Mumbai, Maharashtra, India | |||
| Sharon Bio-Medicine Limited | ₹204.22 Cr (FY 2025) | -20.0% | Panvel, Maharashtra, India | |||
| Orch Laboratories India Private Limited | ₹203 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Inogent Laboratories Private Limited, buy the company report.
Auditor
Inogent Laboratories Private Limited is audited by BRAHMAYYA & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BRAHMAYYA & CO | FY 2016 | 000513S |
Shareholding
The shareholding of Inogent Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Inogent Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jun 2016 | 100037913 | Others | ₹85 Cr | Satisfied | |
| 03 Mar 2010 | 10208872 | Canara Bank | ₹20 Cr | Satisfied |
To see the full charge records of Inogent Laboratories Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Inogent Laboratories Private Limited has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹39 Cr; the latest was in September 2016.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2016 | Acquisition | Undisclosed | Buyer: Aragen Life Sciences Limited Seller: GVK Davix Technologies Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: Aragen Life Sciences Limited Seller: Dai-Ichi Karkaria Limited |
| Jun 2014 | Secondary share transfer | Undisclosed | Buyer: Aragen Life Sciences Limited , GVK Davix Technologies Private Limited Seller: Dai-Ichi Karkaria Limited |
| Dec 2008 | Funding round | ₹36 Cr | Investors: Aragen Life Sciences Limited , GVK Davix Technologies Private Limited , Dai-Ichi Karkaria Limited |
| Sep 2007 | Secondary share transfer | Undisclosed | Buyer: Aragen Life Sciences Limited Seller: an individual |
To see the full deal history of Inogent Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Inogent Laboratories Private Limited has 11 court cases on record: 9 filed by Inogent Laboratories, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 1 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Millennium Industries | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by Matrix Cellular Private Limited | Disposed |
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ganga Ram Chela Ramani Corporation | Disposed |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against Ganga Ram Chela Ramani Corporation | Disposed |
To see the full case history of Inogent Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Inogent Laboratories Private Limited was last rated by Crisil on 21 Mar 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 21 Mar 2018 |
To see the full credit ratings and regulatory alerts of Inogent Laboratories Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inogent Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inogent Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCI3898N1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Inogent Laboratories Private Limited, buy the company report.
Recent activity
Inogent Laboratories Private Limited has 6 board changes on record since 2005: 4 appointments and 2 cessations. The latest: Manmahesh Kantipudi ceased to be Additional Director on 20 Sep 2016.
3 earlier events are in the company report.
Frequently asked questions
Inogent Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Inogent Laboratories was a private limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 01 June 2005 and is registered under CIN U24239TG2005PTC046402. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Inogent Laboratories was incorporated on 01 June 2005. It is registered with the Registrar of Companies, Hyderabad.
Inogent Laboratories had 4 directors:
- Venkata Krishna Reddy Gunupati - Director
- Venkata Sanjayreddy Gunupati - Director
- Davinder Singh Brar - Director
- Manmahesh Kantipudi - Director
The CIN (Corporate Identification Number) of Inogent Laboratories is U24239TG2005PTC046402. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Inogent Laboratories is at Plot 28A Ida Nacharam, Hyderabad, Telangana, India – 500076.
Inogent Laboratories can be reached through the website inogent.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Inogent Laboratories on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 17 July 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Inogent Laboratories is 36AABCI3898N1ZV, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
Inogent Laboratories operated in the pharma industry, in the api manufacturers segment.
Inogent Laboratories has 6 deals on record (3 secondary share transfers, 2 funding rounds, 1 acquisition), with disclosed funding of ₹39 Cr; the latest was in September 2016.